A carregar...
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
Background: A phase III trial demonstrated that cetuximab is the first agent in 30 years to improve survival when added to platinum-based chemotherapy (platinum-fluorouracil) first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). This analysis of the trial a...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2946862/ https://ncbi.nlm.nih.gov/pubmed/20335368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdq077 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|